Involvement of vascular peroxidase 1 in angiotensin II-induced vascular smooth muscle cell proliferation

Cardiovascular Research

Volumn 91, Issue 1, 2011, Pages 27-36

  Shi, Ruizheng ^a   Hu, Changping ^b   Yuan, Qiong ^b   Yang, Tianlun ^a   Peng, Jun ^b   Li, Yuanjian ^b   Bai, Yongping ^a   Cao, Zehong ^c   Cheng, Guangjie ^c   Zhang, Guogang ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

^c University of Alabama at Birmingham   (United States)

Author keywords

Hypertension; Proliferation; Rat aortic smooth muscle cells; Vascular peroxidase 1; Vascular remodelling

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ANGIOTENSIN II; APOCYNIN; CATALASE; HYDROGEN PEROXIDE; PEROXIDASE; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG; VASCULAR PEROXIDASE 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL WALL THICKNESS; ARTERY DIAMETER; ARTICLE; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; HYPERTENSION; MALE; MORPHOLOGY; NONHUMAN; PEROXIDATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; UPREGULATION; VASCULAR SMOOTH MUSCLE;

ANALYSIS OF VARIANCE; ANGIOTENSIN II; ANIMALS; AORTA, THORACIC; CELL PROLIFERATION; CELLS, CULTURED; DISEASE MODELS, ANIMAL; ENZYME ACTIVATION; ENZYME INHIBITORS; EXTRACELLULAR MATRIX PROTEINS; FREE RADICAL SCAVENGERS; HYDROGEN PEROXIDE; HYPERTENSION; HYPOCHLOROUS ACID; MALE; MESENTERIC ARTERIES; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NADPH OXIDASE; PEROXIDASE; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RNA INTERFERENCE; RNA, MESSENGER; SIGNAL TRANSDUCTION; TIME FACTORS;

EID: 79958836580     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvr042     Document Type: Article

References (30)

1. Gibbons GH, Dzau VJ. The emerging concept of vascular remodeling. N Engl J Med 1994;330:1431-1438. (Pubitemid 24139238)
2. Dzau VJ, Gibbons GH, Morishita R, Pratt RE. New perspectives in hypertention research: potentials of vascular biology. Hypertension 1994;23:1132-1140. (Pubitemid 24180878)
3. Zafari AM, Ushio-Fukai M, Akers M, Yin Q, Shah A, Harrison DG et al. Role of NADH/NADPH oxidase-derived H2O2 in angiotensin II-induced vascular hypertrophy. Hypertension 1998;32:488-495. (Pubitemid 28429138)
4. Zhang M, Dong Y, Xu J, Xie Z, Wu Y, Song P et al. Thromboxane receptor activates the AMP-activated protein kinase in vascular smooth muscle cells via hydrogen peroxide. Circ Res 2008;102:328-337. (Pubitemid 351271653)
5. Blanc A, Pandey NR, Srivastava AK. Synchronous activation of ERK 1/2, p38mapk and PKB/Akt signaling by H2O2 in vascular smooth muscle cells: potential involvement in vascular disease. Int J Mol Med 2003;11:229-234.
6. Klebanoff SJ. Myeloperoxidase: friend and foe. J Leukoc Biol 2005;77:598-625. (Pubitemid 40628741)
7. Kettle AJ, Winterbourn CC. Myeloperoxidase: a key regulator of neutrophil oxidant production. Redox Rep 1997;3:3-15. (Pubitemid 27199160)
8. McKenna SM, Davies KJ. The inhibition of bacterial growth by hypochlorous acid. Possible role in the bactericidal activity of phagocytes. Biochem 1988;254:685-692.
9. Weiss SJ, Slivka A. Monocyte and granulocyte-mediated tumor cell destruction. A role for the hydrogen peroxide-myeloperoxidase-chloride system. J Clin Invest 1982; 69:255-262. (Pubitemid 12177602)
10. Heinecke JW. Mechanisms of oxidative damage by myeloperoxidase in atherosclerosis and other inflammatory disorders. J Lab Clin Med 1999;133:321-325. (Pubitemid 29373028)
11. Winterbourn CC. Comparative reactivities of various biological compounds with myeloperoxidase-hydrogen peroxide-chloride, and similarity of the oxidant to hypochlorite. Biochim Biophys Acta 1985;840:204-210. (Pubitemid 15049536)
12. Cheng G, Salerno JC, Cao Z, Pagano PJ, Lambeth JD. Identification and characterization of VPO1, a new animal heme-containing peroxidase. Free Radic Biol Med 2008;45:1682-1694.
13. Juliet MP, Christine CW, Margret CMV. The effect of hypochlorous acid on the expression of adhesion molecules and activation of NF-kB in cultured human endothelial cells. Antioxid Redox Signal 2002;4:5-15.
14. Deiana L, Carru C, Pes G, Tadolini B. Spectrophotometric measurement of hydroperoxides at increased sensitivity by oxidation of Fe2+ in the presence of xylenol orange. Free Radic Res 1999;31:237-244. (Pubitemid 29435886)
15. Dypbukt JM, Bishop C, Brooks WM, Thong B, Eriksson H, Kettle AJ. A sensitive and selective assay for chloramine production by myeloperoxidase. Free Radic Biol Med 2005;39:1468-1477. (Pubitemid 41547227)
16. Zhang Y, Griendling KK, Dikalova A, Owens GK, Taylor WR. Vascular hypertrophy in angiotensin II-induced hypertension is mediated by vascular smooth muscle cellderived H2O2. Hypertension 2005;46:732-737. (Pubitemid 43186746)
17. Zhou X, Bohlen HG, Miller SJ, Unthank JL. NAD(P)H oxidase-derived peroxide mediates elevated basal and impaired flow-induced NO production in SHR mesenteric arteries in vivo. Am J Physiol Heart Circ Physiol 2008;295:H1008-H1016.
18. Heeneman S, Sluimer JC, Daemen MJ. Angiotensin-converting enzyme and vascular remodeling. Circ Res 2007;101:441-454. (Pubitemid 47347875)
19. Guo J, Chen H, Ho J, Mancini J, Sontag T, Laporte SA et al. TGFb-induced GRK2 expression attenuates AngII-regulated vascular smooth muscle cell proliferation and migration. Cell Signal 2009;21:899-905.
20. Mu H, Wang X, Lin PH, Yao Q, Chen C. Chlorotyrosine promotes human aortic smooth muscle cell migration through increasing superoxide anion production and ERK1/2 activation. Atherosclerosis 2008;201:67-75.
21. Baldus S, Eiserich JP, Mani A, Castro L, Figueroa M, Chumley P et al. Endothelial transcytosis of myeloperoxidase confers specificity to vascular ECM proteins as targets of tyrosine nitration. J Clin Invest 2001;108:1759-1770. (Pubitemid 34015121)
22. Zhang C, Yang J, Jacobs JD, Jennings LK. Interaction of myeloperoxidase with vascular NAD(P)H oxidase-derived reactive oxygen species in vasculature: implications for vascular diseases. Am J Physiol Heart Circ Physiol 2003;285: H2563-H2572. (Pubitemid 37443074)
23. Brennan ML, Anderson MM, Shih DM, Qu XD, Wang X, Mehta AC et al. Increased atherosclerosis in myeloperoxidase-deficient mice. J Clin Invest 2001;107: 419-430. (Pubitemid 32167988)
24. Castellani LW, Chang JJ, Wang X, Lusis AJ, Reynolds WF. Transgenic mice express human MPO -463G/A alleles at atherosclerotic lesions, developing hyperlipidemia and obesity in -463G males. J Lipid Res 2006;47: 1366-1377. (Pubitemid 44079890)
25. Zhao Q, Ishibashi M, Hiasa K, Tan C, Takeshita A, Egashira K. Essential role of vascular endothelial growth factor in angiotensin II-induced vascular inflammation and remodeling. Hypertension 2004;44:264-270. (Pubitemid 39172204)
26. Ginnan R, Guikema BJ, Halligan KE, Singer HA, Jourd'heuil D. Regulation of smooth muscle by inducible nitric oxide synthase and NADPH oxidase in vascular proliferative diseases. Free Radic Biol Med 2008;44:1232-1245.
27. Touyz RM. Intracellular mechanisms involved in vascular remodelling of resistance arteries in hypertension: role of angiotensin II. Exp Physiol 2005;90:449-455. (Pubitemid 40980144)
28. Rajagopalan S, Kurz S, Munzel T, Tarpey M, Freeman BA, Griendling KK et al. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J Clin Invest 1996;97:1916-1923.
29. Virdis A, Neves MF, Amiri F, Touyz RM, Schiffrin EL. Role of NAD(P)H oxidase on vascular alterations in angiotensin II-infused mice. J Hypertens 2004;22:535-542. (Pubitemid 38368487)
30. Midwinter RG, Vissers MC, Winterbourn CC. Hypochlorous acid stimulation of the mitogen-activated protein kinase pathway enhances cell survival. Arch Biochem Biophys 2001;394:13-20. (Pubitemid 32948279)